NASDAQ:SILKSilk Road Medical Stock Price, Forecast & News

Silk Road Medical's stock was trading at $37.14 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SILK shares have increased by 7.3% and is now trading at $39.85. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Silk Road Medical.

Silk Road Medical is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Silk Road Medical.

Silk Road Medical Inc (NASDAQ:SILK) posted its quarterly earnings data on Thursday, April, 30th. The company reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.31) by $0.01. The business had revenue of $18.93 million for the quarter, compared to analyst estimates of $19.79 million. Silk Road Medical had a negative net margin of 54.94% and a negative return on equity of 44.17%. The company's revenue for the quarter was up 48.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($20.12) earnings per share. View Silk Road Medical's earnings history.

3 brokers have issued 1-year target prices for Silk Road Medical's shares. Their forecasts range from $47.00 to $52.00. On average, they expect Silk Road Medical's stock price to reach $49.67 in the next year. This suggests a possible upside of 24.6% from the stock's current price. View analysts' price targets for Silk Road Medical.

Press coverage about SILK stock has trended somewhat positive this week, InfoTrie reports. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Silk Road Medical earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future. View the latest news aboutSilk Road Medical.

Silk Road Medical saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 2,270,000 shares, an increase of 5.6% from the April 15th total of 2,150,000 shares. Based on an average daily volume of 323,700 shares, the short-interest ratio is currently 7.0 days. Approximately 9.8% of the company's shares are short sold. View Silk Road Medical's Current Options Chain.

Some companies that are related to Silk Road Medical include Tandem Diabetes Care (TNDM), Integra Lifesciences (IART), Nevro (NVRO), ICU Medical (ICUI), Irhythm Technologies (IRTC), NuVasive (NUVA), Merit Medical Systems (MMSI), Inspire Medical Systems (INSP), Glaukos (GKOS), Inovio Pharmaceuticals (INO), Cantel Medical (CMD), AtriCure (ATRC), Luminex (LMNX), Shockwave Medical (SWAV) and Cardiovascular Systems (CSII). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Alibaba Group (BABA), Cisco Systems (CSCO), Home Depot (HD), Honeywell International (HON), Splunk (SPLK), Thermo Fisher Scientific (TMO), CVS Health (CVS), DexCom (DXCM), Raytheon Technologies (RTX) and Veeva Systems (VEEV).

(SILK) raised $75 million in an initial public offering on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

Silk Road Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Capital World Investors (5.64%), BlackRock Inc. (5.29%), Janus Henderson Group PLC (5.22%), Alliancebernstein L.P. (4.63%), Wasatch Advisors Inc. (4.60%) and Jennison Associates LLC (4.26%). Company insiders that own Silk Road Medical stock include Andrew S Davis, Erica J Rogers, Lucas W Buchanan, Pincus & Co Warburg, Richard Ruedy and X Finance LP Wp. View institutional ownership trends for Silk Road Medical.

SILK stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Janus Henderson Group PLC, Alyeska Investment Group L.P., Atom Investors LP, TimesSquare Capital Management LLC, Cannell Peter B & Co. Inc., Rhenman & Partners Asset Management AB, and Nuveen Asset Management LLC. Company insiders that have sold Silk Road Medical company stock in the last year include Andrew S Davis, Erica J Rogers, Lucas W Buchanan, Pincus & Co Warburg, and Richard Ruedy. View insider buying and selling activity for Silk Road Medical.

SILK stock was purchased by a variety of institutional investors in the last quarter, including Capital World Investors, Wasatch Advisors Inc., Invesco Ltd., Capital International Investors, Frontier Capital Management Co. LLC, Clearbridge Investments LLC, BlackRock Inc., and Thrivent Financial for Lutherans. View insider buying and selling activity for Silk Road Medical.

Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SILK stock can currently be purchased for approximately $39.85.

Silk Road Medical has a market capitalization of $1.25 billion and generates $63.35 million in revenue each year. The company earns $-52,420,000.00 in net income (profit) each year or ($1.36) on an earnings per share basis. Silk Road Medical employs 176 workers across the globe.

The official website for Silk Road Medical is www.silkroadmed.com.

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The company can be reached via phone at 408-720-9002 or via email at [email protected]